+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Allergy Immunotherapy Market by Treatment Type, Allergen Type, Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Allergy Immunotherapy Market by Treatment Type, Allergen Type, Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Allergy Immunotherapy Market by Treatment Type, Allergen Type, Immunotherapy Delivery Form, Technology Platform, Allergy Type, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905050
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Allergy Immunotherapy Market grew from USD 1.86 billion in 2024 to USD 2.04 billion in 2025. It is expected to continue growing at a CAGR of 10.03%, reaching USD 3.30 billion by 2030.

Allergy immunotherapy is transforming the healthcare landscape through innovative treatments and patient-centered care. In recent years, the field has undergone significant advancements that respond to a global rise in allergic diseases. With a scientific foundation built on decades of research, this dynamic area is not only modernizing treatment protocols but also integrating advanced diagnostics and personalized care strategies. The concept of immunotherapy extends beyond conventional allergy management, aiming to recalibrate the body’s immune responses through targeted interventions. Stakeholders across the spectrum - clinicians, researchers, and industry leaders - are recognizing the urgent need to align clinical practices with these groundbreaking developments. This report sets the stage by exploring the fundamental drivers of change, the impact of emerging scientific insights, and the evolving regulatory landscapes that continue to shape treatment modalities in allergy immunotherapy. Through a comprehensive review, the narrative paves the way for a deeper understanding of the market forces at play and invites stakeholders to engage with data-driven insights.

Transformative Shifts Redefining the Treatment Landscape

A paradigm shift is underway in the field of allergy immunotherapy as the convergence of technological innovations and enhanced clinical insights redefines treatment strategies. New delivery systems inspired by advances in biotechnology have unlocked alternative pathways to address allergies with greater precision. The infusion of nanotechnology and recombinant allergen platforms, combined with robust data analytics, is accelerating the pace at which therapies are developed and optimized. This transformation is evidenced by the seamless integration of novel diagnostic tools and patient monitoring systems to ensure treatment efficacy and adherence. As the market evolves, there is an increased focus on personalized treatment regimens, paving the way for tailored solutions that address individual patient profiles. This dynamic shift has encouraged collaborations between research institutions and biotechnology firms, while fostering a climate of innovation that is essential for meeting the complex challenges posed by allergic disorders. The resultant landscape is one where agility, scientific rigor, and strategic investment are paramount in driving sustainable growth.

Comprehensive Segmentation Insights Driving Market Understanding

A granular examination of the allergy immunotherapy market reveals a multifaceted segmentation strategy that underpins industry insights. The analysis based on treatment type carefully explores distinctions among Epicutaneous Immunotherapy, Oral Immunotherapy, Subcutaneous Immunotherapy, and Sublingual Immunotherapy. Complementarily, a segmentation based on allergen type dissects the treatment landscape into areas such as Animal Dander, Dust Mites, Food Allergens, and Pollen. Within the allergen category, further refinement is observed in the focus on Cat and Dog Allergens as subcategories of Animal Dander, and Egg, Milk, Peanut, and Tree Nut Allergens as subdivisions of Food Allergens. The market is also stratified by immunotherapy delivery forms, including Dermal Patch, Drops, Injections, and Tablets, underscoring the importance of controlled administration methods. Additionally, technology platform segmentation highlights the role of Adjuvants, Nanotechnology-Based Platforms, and Recombinant Allergens in steering treatment innovation. Alongside these, the segmentation based on allergy type examines Allergic Asthma, Allergic Rhinitis, Atopic Dermatitis, and Urticaria, while end user considerations span Homecare Settings, Hospitals, Research & Academic Laboratories, and Specialty Clinics. Finally, a review of the distribution channel encompasses insights into Hospital, Online, and Retail Pharmacy channels, painting a complete picture of market dynamics.

Based on Treatment Type, market is studied across Epicutaneous Immunotherapy, Oral Immunotherapy, Subcutaneous Immunotherapy, and Sublingual Immunotherapy.

Based on Allergen Type, market is studied across Animal Dander, Dust Mites, Food Allergens, and Pollen. The Animal Dander is further studied across Cat Allergens and Dog Allergens. The Food Allergens is further studied across Egg Allergens, Milk Allergens, Peanut Allergens, and Tree Nut Allergens.

Based on Immunotherapy Delivery Form, market is studied across Dermal Patch, Drops, Injections, and Tablets.

Based on Technology Platform, market is studied across Adjuvants, Nanotechnology-Based Platforms, and Recombinant Allergens.

Based on Allergy Type, market is studied across Allergic Asthma, Allergic Rhinitis, Atopic Dermatitis, and Urticaria.

Based on End User, market is studied across Homecare Settings, Hospitals, Research & Academic Laboratories, and Specialty Clinics.

Based on Distribution Channel, market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Regional Insights Shaping Global Market Dynamics

Regional trends have a profound impact on the strategic direction of the allergy immunotherapy market. The Americas continue to be a hotbed of growth, driven by a combination of favorable regulatory frameworks and a proactive approach to healthcare innovation. Emerging opportunities in this region are complemented by robust research initiatives and significant investments in state-of-the-art medical technologies. In contrast, the Europe, Middle East & Africa region exhibits a blend of mature markets and evolving landscapes. Here, the emphasis is placed on quality of care and stringent safety standards, which serve as catalysts for incremental advancements and continuity in treatment quality. The Asia-Pacific region is rapidly emerging as a leader in market growth, buoyed by its expanding healthcare infrastructure, rising patient awareness, and a sustained drive towards research and development. Each region presents unique challenges and opportunities that influence the overall growth trajectory of the market; understanding these regional paradigms is critical for stakeholders intent on harnessing new opportunities and addressing localized needs in allergy immunotherapy.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

In-Depth Company Insights Shaping Market Leaders

Key players in the allergy immunotherapy market are at the forefront of research, innovation, and commercialization efforts. Several prominent companies are redefining industry standards by leveraging their extensive expertise and embracing cutting-edge technologies. Firms such as Adamis Pharmaceuticals Corporation and ALK-Abelló, Inc. have underscored the importance of strategic investments in clinical research, a sentiment echoed by Allergy Therapeutics PLC and Anergis SA. This commitment is further reflected in the progress made by ASIT Biotech, which has emerged as a notable player in the market. Other industry forerunners including Biomay AG and Biomunex Pharmaceuticals SAS have also contributed significantly to bolstering market credibility through innovative approaches and expansive research portfolios. Alongside these, companies like BioSpace, Inc. and Circassia Group PLC are instrumental in advancing therapeutic applications, while DBV Technologies SA and Eli Lilly and Company provide additional momentum with robust R&D programs. Global enterprises such as F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, HAL Allergy B.V., and the transformative contributions from HollisterStier Allergy by Jubilant Pharma Company, among others, are pivotal in shaping the emerging trends and future directions of the market. Concerted efforts from industry leaders, including those from Jubilant HollisterStier LLC, LETI Pharma, S.L.U., Merck KGaA, Mylan N.V. by Viatris Inc., NOVARTIS AG, Sanofi S.A, Stallergenes Greer International AG, Stallergenes Greer Ltd, and Torii Pharmaceutical Co., Ltd., further underscore the collaborative impetus driving innovation and market expansion.

The report delves into recent significant developments in the Allergy Immunotherapy Market, highlighting leading vendors and their innovative profiles. These include Adamis Pharmaceuticals Corporation, ALK-Abelló, Inc., Allergy Therapeutics PLC, Anergis SA, ASIT Biotech by DMS Imaging, ASIT Biotech SA, Biomay AG, Biomunex Pharmaceuticals SAS, BioSpace, Inc., Circassia Group PLC, DBV Technologies SA, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, HAL Allergy B.V., HollisterStier Allergy by Jubilant Pharma Company, Jubilant HollisterStier LLC, LETI Pharma, S.L.U., Merck KGaA, Mylan N.V. by Viatris Inc., NOVARTIS AG, Sanofi S.A, Stallergenes Greer International AG, Stallergenes Greer Ltd, and Torii Pharmaceutical Co., Ltd..

Actionable Recommendations for Industry Leaders

For decision-makers and industry stakeholders, several strategic recommendations emerge from the evolving landscape of allergy immunotherapy. First and foremost, investing in research and development is paramount - continuous innovation in treatment modalities and delivery platforms is the key to maintaining a competitive edge. Embracing advances in nanotechnology and biotechnology can not only foster more accurate and personalized therapy solutions but also ensure the scalability of treatments across diverse patient demographics. Leaders should capitalize on digital transformation by integrating comprehensive data analytics to monitor clinical outcomes, optimize treatment efficiencies, and streamline supply chain operations. Additionally, fostering cross-sector collaborations with academic institutions and biotechnology firms can drive forward research initiatives and accelerate the rate of clinical breakthroughs. It is also critical to harmonize regulatory compliance and invest in quality assurance measures that align with the highest global standards. Finally, market leaders should consider diversifying distribution channels and investing in direct-to-patient engagement strategies, which are essential to broaden market reach and solidify long-term growth. By following these actionable insights, industry leaders can proactively adapt to market disruptions while ensuring sustainable success in a rapidly evolving arena.

In conclusion, the current overview of the allergy immunotherapy sector underscores a multifaceted evolution fueled by scientific advancements, technological integrations, and strategic market segmentation. The integration of novel treatment approaches, innovative technology platforms, and diversified delivery forms elucidates a comprehensive picture of a market in transition. Regional dynamics continue to influence the expansion and customization of therapies, while the presence of key industry players underscores a collaborative effort toward continuous improvement and innovation. This evolving landscape, marked by significant investment in research and development and bolstered by progressive regulatory frameworks, presents a compelling case for stakeholders to review and update their strategic priorities. The journey toward personalized and efficient treatments is becoming increasingly pivotal, with industry leaders now having a unique opportunity to align themselves with future trends while driving significant patient outcomes and clinical excellence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of allergic conditions raises demand for allergy immunotherapy solutions
5.1.1.2. Government initiatives and favorable healthcare policies supporting the integration of immunotherapy
5.1.1.3. Increasing awareness and diagnosis of allergies contributes to the demand for innovative treatments
5.1.2. Restraints
5.1.2.1. High cost of developing allergy immunotherapy limits accessibility for patients and healthcare systems
5.1.3. Opportunities
5.1.3.1. Developing allergy immunotherapy solutions addressing cross-reactive allergens prevalent in multiple regions
5.1.3.2. Expansion potential of digital platforms for remote consultations and telehealth allergy care services
5.1.4. Challenges
5.1.4.1. Stringent regulatory frameworks and lengthy approval processes for new product launches
5.2. Market Segmentation Analysis
5.2.1. Treatment Type: Rising need for sublingual immunotherapy for treating pollen and dust mite allergies
5.2.2. End User: Growing significance of allergy immunotherapy in hospitals to manage chronic allergies
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Allergy Immunotherapy Market, by Treatment Type
6.1. Introduction
6.2. Epicutaneous Immunotherapy
6.3. Oral Immunotherapy
6.4. Subcutaneous Immunotherapy
6.5. Sublingual Immunotherapy
7. Allergy Immunotherapy Market, by Allergen Type
7.1. Introduction
7.2. Animal Dander
7.2.1. Cat Allergens
7.2.2. Dog Allergens
7.3. Dust Mites
7.4. Food Allergens
7.4.1. Egg Allergens
7.4.2. Milk Allergens
7.4.3. Peanut Allergens
7.4.4. Tree Nut Allergens
7.5. Pollen
8. Allergy Immunotherapy Market, by Immunotherapy Delivery Form
8.1. Introduction
8.2. Dermal Patch
8.3. Drops
8.4. Injections
8.5. Tablets
9. Allergy Immunotherapy Market, by Technology Platform
9.1. Introduction
9.2. Adjuvants
9.3. Nanotechnology-Based Platforms
9.4. Recombinant Allergens
10. Allergy Immunotherapy Market, by Allergy Type
10.1. Introduction
10.2. Allergic Asthma
10.3. Allergic Rhinitis
10.4. Atopic Dermatitis
10.5. Urticaria
11. Allergy Immunotherapy Market, by End User
11.1. Introduction
11.2. Homecare Settings
11.3. Hospitals
11.4. Research & Academic Laboratories
11.5. Specialty Clinics
12. Allergy Immunotherapy Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Americas Allergy Immunotherapy Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Allergy Immunotherapy Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Allergy Immunotherapy Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Scenario Analysis
16.3.1. Stallergenes Greer strengthens Nordic presence with new affiliate for allergen immunotherapy
16.3.2. Australia initiates groundbreaking peanut allergy treatment program for infants
16.3.3. FDA approves Xolair to mitigate allergic reactions from multiple food allergens
16.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ALLERGY IMMUNOTHERAPY MARKET MULTI-CURRENCY
FIGURE 2. ALLERGY IMMUNOTHERAPY MARKET MULTI-LANGUAGE
FIGURE 3. ALLERGY IMMUNOTHERAPY MARKET RESEARCH PROCESS
FIGURE 4. ALLERGY IMMUNOTHERAPY MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2024 VS 2030 (%)
FIGURE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2024 VS 2030 (%)
FIGURE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2024 VS 2030 (%)
FIGURE 17. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 19. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 21. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 25. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 30. ALLERGY IMMUNOTHERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 31. ALLERGY IMMUNOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ALLERGY IMMUNOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ALLERGY IMMUNOTHERAPY MARKET DYNAMICS
TABLE 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EPICUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ORAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBCUTANEOUS IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SUBLINGUAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY CAT ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DOG ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DUST MITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY EGG ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY MILK ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY PEANUT ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREE NUT ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY POLLEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ADJUVANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY NANOTECHNOLOGY-BASED PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RECOMBINANT ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY URTICARIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 79. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 80. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 81. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 82. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 83. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 90. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 91. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 92. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. MEXICO ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 125. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 126. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 127. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 128. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 129. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 130. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 134. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 135. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 136. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 137. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 138. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 139. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 152. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 153. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 154. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 155. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 156. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 193. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 202. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. TAIWAN ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 205. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 206. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 207. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 208. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 209. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 210. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 211. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. THAILAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 218. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 220. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. VIETNAM ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 232. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 233. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 234. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 235. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 236. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 237. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 238. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 239. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. DENMARK ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 242. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 243. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 244. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 245. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 246. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 247. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 248. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. EGYPT ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 251. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 252. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 253. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 254. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 255. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 256. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 257. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. FINLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 260. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 261. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 262. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 263. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 264. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 265. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 266. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 269. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 270. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 271. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 272. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 273. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 274. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 275. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 287. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 288. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 289. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 290. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 291. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 292. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 293. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 314. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 315. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 316. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 317. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 318. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 319. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 320. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. NORWAY ALLERGY IMMUNOTHERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 323. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
TABLE 324. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ANIMAL DANDER, 2018-2030 (USD MILLION)
TABLE 325. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
TABLE 326. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY IMMUNOTHERAPY DELIVERY FORM, 2018-2030 (USD MILLION)
TABLE 327. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 328. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 329. POLAND ALLERGY IMMUNOTHERAPY MARKET SIZE, BY END USER, 20

Companies Mentioned

  • Adamis Pharmaceuticals Corporation
  • ALK-Abelló, Inc.
  • Allergy Therapeutics PLC
  • Anergis SA
  • ASIT Biotech by DMS Imaging
  • ASIT Biotech SA
  • Biomay AG
  • Biomunex Pharmaceuticals SAS
  • BioSpace, Inc.
  • Circassia Group PLC
  • DBV Technologies SA
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • HAL Allergy B.V.
  • HollisterStier Allergy by Jubilant Pharma Company
  • Jubilant HollisterStier LLC
  • LETI Pharma, S.L.U.
  • Merck KGaA
  • Mylan N.V. by Viatris Inc.
  • NOVARTIS AG
  • Sanofi S.A
  • Stallergenes Greer International AG
  • Stallergenes Greer Ltd
  • Torii Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.3 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Allergy Immunotherapy Market Report and Forecast 2024-2032 - Product Image

Allergy Immunotherapy Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Allergy Immunotherapy - Global Strategic Business Report - Product Image

Allergy Immunotherapy - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Allergy Immunotherapies Market Report by Treatment Type, Allergy Type, Distribution Channel, and Region 2025-2033 - Product Image

Allergy Immunotherapies Market Report by Treatment Type, Allergy Type, Distribution Channel, and Region 2025-2033

  • Report
  • 146 Pages
  • Global
From
Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (Subcutaneous Immunotherapy) By Type, By Allergy Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (Subcutaneous Immunotherapy) By Type, By Allergy Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Pollen Allergy Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Pollen Allergy Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From

About the Allergy Immunotherapy Market

Allergy Immunotherapy is a form of treatment for allergies that involves administering small doses of allergens to the patient over a period of time. This helps the patient build up a tolerance to the allergens, reducing the severity of their allergic reactions. Allergy Immunotherapy is often used in conjunction with other forms of allergy treatment, such as antihistamines and decongestants. Allergy Immunotherapy is a growing market, with a variety of products available to treat different types of allergies. These products range from sublingual drops and tablets to injections and nasal sprays. Many of these products are available over the counter, while others require a prescription from a doctor. The Allergy Immunotherapy market is highly competitive, with many companies offering products to treat different types of allergies. Some of the major players in the market include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, and Circassia. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.